Temozolomid-Teva 5 mg
Temozolomid-Teva 5 mg is a medicine authorised by Swissmedic under authorisation number 61225. The authorisation holder is Teva Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 14 October 2010 and the authorisation is valid without a time limit. ATC code L01AX03 places the medicine in the group Antineoplastic agents.
| Authorisation number | 61225 |
|---|---|
| Name | Temozolomid-Teva 5 mg |
| Full name | Temozolomid-Teva 5 mg, Kapseln |
| Authorisation holder | Teva Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01AX03 |
| First authorisation | 14 October 2010 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Temozolomid-Teva 5 mg, Kapseln | A | 14 October 2010 |
| 2 | Temozolomid-Teva 20 mg, Kapseln | A | 14 October 2010 |
| 3 | Temozolomid-Teva 100 mg, Kapseln | A | 14 October 2010 |
| 4 | Temozolomid-Teva 140 mg, Kapseln | A | 14 October 2010 |
| 5 | Temozolomid-Teva 180 mg, Kapseln | A | 14 October 2010 |
| 6 | Temozolomid-Teva 250 mg, Kapseln | A | 14 October 2010 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 5 | Kapsel(n) | L01AX03 | 07.16.1. | A |
| 2 | 20 | Kapsel(n) | L01AX03 | 07.16.1. | A |
| 3 | 5 | Kapsel(n) | L01AX03 | 07.16.1. | A |
| 4 | 20 | Kapsel(n) | L01AX03 | 07.16.1. | A |
| 5 | 5 | Kapsel(n) | L01AX03 | 07.16.1. | A |
| 6 | 20 | Kapsel(n) | L01AX03 | 07.16.1. | A |
| 7 | 5 | Kapsel(n) | L01AX03 | 07.16.1. | A |
| 8 | 20 | Kapsel(n) | L01AX03 | 07.16.1. | A |
| 9 | 5 | Kapsel(n) | L01AX03 | 07.16.1. | A |
| 10 | 20 | Kapsel(n) | L01AX03 | 07.16.1. | A |
| 11 | 5 | Kapsel(n) | L01AX03 | 07.16.1. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Temozolomid-Teva 5 mg authorised in Switzerland?
Yes. Temozolomid-Teva 5 mg is authorised by Swissmedic under authorisation number 61225, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Temozolomid-Teva 5 mg have?
Temozolomid-Teva 5 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Temozolomid-Teva 5 mg?
The authorisation holder is Teva Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.